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percutaneous balloon aortic valvnloplasly has been accompanied
by significzmtearly periprocedural morbidity and mortality . Iden-
tification of factors associated with increased mortality might
allow far improved selection of patients . The Mansfield Scientific
Balloon Aortic Vahulopfa iv Registry was analyzed to identify the
frequency of in-hospital death and the factors associated with it .
01`492 patients undergoing the procedure, 37 (7 .5%) died during
the hospital stay im
which valvuloplasty was performed . Twenty-
four of these patients died within The first 24 h and the remainder
d-ted within 7 days after the procedure .
Marx were significant di0eredces in baseline clinical and
Balloon aortic valvnloplasty has been used to treat severe
aortic stunosis in patients who are at high risk for aortic
valve replacement 11-51. This high risk group includes very
elderly patients, those with depressed left ventricular func-
tion and those with associated medical conditions that make
conventional treatment with aortic valve replacement less
optimal . Valvuloplasty in these patients results in moderate
improvement in aortic valve hemodynamics 12 .3 .6.71. There
is. however, a substantial incidence of early complications.
including vascular entry problems, ventricular arrhythmias
.
left ventricular perforation and death (2-5 .8). Identification
of factors associated with increased early mortality would
improve patient selection and perhaps outcome
. This study
analyzed data from the Mansfield Scientific Balloon Aortic
Valvuloplasty Registry to assess early mortality and identify
clinical, hemodynamic and procedural factors associated
with early death .
Methods
Selection of patients . The Mansfield Scientific Balloon .Aor-
lie Valvuloplasty Registry is an industry-sponsored study per-
formed under the auspices of a Food and Drug Administration,
approved investigational device exemption . A, part of an early
evaluation of the vafeto and efficacy of percutaneous balloon
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hemodynamic characteristic as well as procedural and postpro-
cedural variables between patients dying and those mrvb mg the
in-hospital period . Multivariate analysis identified four factors
associated with increased mortality: 11 the ocewrenoee of a penee-
dure-related cowrplicatiau, 21 a lower initial left ventricular sys-
tolic pressure, 3) a smaller final aortic valve area, and 4) a lower
baseline cardiac output.
Thus, baseline hemodynattdc, procedural and poslprocedanl
variables and complkatiors
un
be bleotised that are associated
with increased mortality .
(J Am Coll Cardof 1991 ;17
:189-p21
aortic valvulnplasty
. 27 centers prospectively entered baseline
clinical and hemodynamic data . procedural data ardfelldw-up
data on 492 consecutive patients undergoing this procedure for
the treatment of severe aortic stenosis at these centers from
December I . 1958 to October 3u, 1987 . These palientsform the
basis of this report-
The indications for valvuloplasry m each center varied
somewhat . but by recommendation they included sympto-
matic aortic slen0515 with no oronly mild aortic regurgitation
in patients who were not thought to he ideal candidates for
conventional treatment with aortic valve replacement . The
clinical reasons for proceeding with balloon aortic vatvulo-
plasty instead of aortic valve replacement were determined
at each center, but they included advanced age, significant
left ventricular dysfunction, the presence of associated can
diovascular or noneardiac diseases that would adversely
affect surgical treatment or outcome and physician or patient
preference.
Analysis or data (Table 1). In-hospital mortality was
assessed . Factors associated with increased mortality were
identified with univariate analysis . Discrete variables were
tested by chi-square analysis and continuous variables were
assessed with a two-tailed r test . Factors associated with
increased mortality by univariate analysis were further eval-
uated with multivariate discriminant analysis . Beccuse com-
plications of the procedure were found to be an important
predictor of in-hospital death . both univariate and muitivari-
ate analyses were performed to assess factors associated
with complications (Table 1) .
Valvuloplasty was performed in all patients in a manner
similar to that described by Cribier et al. 11 .2) . Success was
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Table 1. Variables Assessed in 492 Patients Undergoing Balloon
Aortic Valvuluplasty
-Measured by indicator dilution, thennodilulion or Fick method .
tSignifcant stenosis was defined as a :50% stenosis of a m jor rpicardial
vessel. NYHA = New York Heart Association.
defined as an increase in valve area of 025% era decrease in
pressure gradient of _>50% and no death or valve replace-
ment within 7 days.
Table 2. Comparison of Patients Who Had Procedure- Related and in-Hospital Death After Balloon
Aonlc Valvuloplasry and Patients Who Survived the Procedure, by Selected Baseline and
Procedural Characteristics
Results
Results of angioplasty
. Of the 492 patients, 219 were men
and 273 were women ; their mean age ± SD was 78.7 t 8 .4
years . The procedure was successful in 428 cases (87%) . The
mean initial aortic valve area increased from 0.50 ± 0.18 to
0.82 ± 0
.30
em', and the average mean gradient decreased
from 59.8 ± 23 .0 to 29.5 = 13 .4 mm Hg (Table 21
.
Of the 492 patients, 37 (7 .5%) died during the hospital
stay in which valvuloplasty was performed. Twenty-four
patients (4.9%) died within the first 24 h after the procedure
and the remainder died between 24 It
and 7 days after the
procedure .
Factors Associated With Mortality
Baseline clinical and hemodynamic factors (Table 2) .
There were significant differences in the baseline clinical and
hemodynamic characteristics of the patients who died during
hospitalization and those who survived the in-hospital pe-
riod . Patients who died had a lower mean initial aortic valve
area (0.40 ± 0.02 versus
0
.51 ± 0.01 can', p < 0 .001), lower
baseline left ventricular systolic pressure (184 * 7 versus
203 ± 2 mm Hg, p < 0 .01) and lower baseline cardiac output
(3 .0 ± 0 .2 versus 3 .9 ± 0 .1 litersbmin,
p < 0.001)
than
survivors. In addition, the incidence of coroit ry artery
'a is given in parentheses for cases in which data were
missing.
lBeneuse of m'ssiag data in some cases, nut all
pNienn in a cusp are accovoled for
. NYHA = New York Meets Association.
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Men. Oscar'
Cllernctedstm Death In - 371 Suroivel 1 . , 4551 p Vales
Gender
Male (Y) 40 45
NS
Fcmslc (%)
60 55
Agv (ye) sever b SD) 80.1±1 .4 78.6±0 .4 N5
Cardiac output lliterdmml 3.11 ± 02116) 1.9 ^ 0 .1 (443) 0 .001
Valve area (can't
0.40
1
0
.02 (30
0.51 x 0014454) 0
.001
Valve gradient (elm Hg) 57.0 *_ 4
.1051 60.0 ± 1 .1 NS
tell ventricular systolic pressure Imm Has 184 ± 7(361 203 T_
2 (4131
0.01
Left vemnemar diastolic pressure Imm Hg) 20m24361 19±114121 N5
NYHA class fit or IV (%) 97(311 8014111 0.012
Real sonic valve area tame) 0.68 a 0.6 127) 0.83 ± 0 .01145-1 ) 0.02
Final valve gradiem (.an Hgl 29.6 ! 4 .01281 29.5 v 0.6 (454) N5
Cheese in valve area (cp,') 0 .27 T 0.06 121) 0 .32 a 0.0[ 4521, N5
Change in valve gradient On . Hg) 74 .0 z 1.5(281 30.1 a 0-8 (454) N5
>_t complication
(0) 73 16 0Am1
Remu is of coronary anericgraphy Ino , of patients)-
Normal 4 172
Mild ascends
7 72 0,05
030)1
_'l-is
16
174
I vessel disease 5
76
2 vessel disease
2 45 NS
3 vessel disease 7
56
Prior myocardial infarelton Yd4 13 .5 10 .1 NS
C:Inical Hemmlynandc
Procedural
Age Left ventricular Maaimal balloon size
Gender systolic pressure One us. two balloons
History of Left ventncular Celepllcolions
myocardial iNaretion
dkerottc pressure Embolic event
symptoms
AarEC valve area
V-1or injury
Dyspnea Mean aortic calve Cardiac arrest
Angina gradient Veotneukmperforaulon
Hart tail- Camiar omput' AomC regure tarion
Syncope AaniC naive
replacement
Fatigue Veetriculartachycardie
NYHAfsneliormldass V .1ricaarOtsiillaluo
Coronary a tery disease' lrr6rcrion
None Hypotension
I vessel Heart Us .
2 vessel
3 vessel
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Table 3
. Mullivariale Analysis in 492 Patients Undergoing Balloon
Aortic Valvuloplasty
V.
rubles subjected to multivariate analysis
Prevalvuloplasty aortic valve area
Left ventricular peak systolic pressure
Cardiac output
Coronary artery disease
Number of inflations performed
Final aortic valve area
Change in aortic valve gradient
Incidence and number of procedure-related eampgcatiuns
Discriminant analysis of variables related to in-hospital death
Peeeedueeaelated complications
Lance initial left ventricular systolic pressure
L..., final sonic valve area
Lower baseline cardiac output
disease in patients who died was significantly higher 185%x,
versus 59%, p < 0
.05).
Procedural factors (Tables 2 and 3) . There were also
significant differences in the procedural and postvalvulo-
plasty variables between survivors and those who died
. The
only hemodynamic variable that was significantly different
was the mean aortic valve area after vaivuloplasty . which
was 0
.68 ± 0 .06 cm' in the patients who died and 0.83
0.01 cm'- in the survivors (p < 0
.021 . Tile frc4uency of
complications also significantly affected outcome . Patients
with one or more complications had a higher incidence of
death (p < 0.001).
Variables identified with univariate analysis were then
tested in a multivariate model (Table 3) . The occurrence of
procedural-related complications was the most important
variable . The patients with an in-hospital complication had a
27% mortality rate, whLraas those with no complications had
a mortality rate of only 2
.6%, The highest mortality rate was
seen in association with myocardial perforation (56%I. ven-
tricular tachycardia or fibrillation (53%) and emergency
valve replacement (33%) . Other variables associated with
increased mortality included the baseline variables of left
ventricular function
. specifically a lower baseline left ven-
tricular systolic pressure and lower initial cardiac output
.
The final variable associated with increased mortality was
final aortic valve area-the lower the final aortic valve area .
the higher the incidence of death .
Factors Associated With Complications
(Tublea I and 4)
Because the occurrence of procedure-related complica-
tions was the most important variable nssaciared with in-
hospital death, an analysis was performed on factors (Table
I) associated with the development of complications- With
univariate analysis . the only two significant variables were
female gender (p -- 0 .04) and the presence of coronary artery
disease (p = 0 .04) . Increasing severity of prevalsntloplasty
functional Class showed a trend toward significance (p =
HOLMES ET AL
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Table 4. Multivariate Analysis of Complications in 492 Patients
Undergoi ng Balloon Aortic Valvuloplasty
Variables included in analysis
Gender
Age
Presen a of cumtary artery disease
Weight
Prevalvulopusty functional clam IN— York Bean Assvviatieet
Use of double balloon technique
First no panes (fatty eapaiencel
Number of balloons used
Variables selected far egressio nwith increased hkeliboad of camptcntions
Female gender
Presence ofmrunary array disease
Mere e baseline fuxtaseal
class ON- York Heart Assuutionl
Deublebal
re
leon technique
Sital] number or patents testy 2%)
0.07) . The use of a double
balloon technique was associated
with a decreased incidence of vascular injury compared with
a single balloon technique (5 .0% versus 12 .7%). This differ-
ence is probably related to the smaller caliber of balloons
used in the double balloon technique . However, patients
who had a double balloon procedure had a slightly increased
incidence of acute aortic regurgitation
.
Variables associated with the presence ofa enmpffcatinn
nere assessed with multivariate analysis (Table 4)
. The
association between these variables and The development of
complications was highly significant (p = 0.0016) ; however,
the model predicted complications accurately in only 58% of
the patients. There was a decrease in the complication rate
over time. In the first half of the study from December 1986
to July 1987, the overall complication rate was 25%. whereas
in the last 231 patients from July 1987 to December 1987. the
complication rate was 10% (p < 0
.05) . This decrease was
primarily related to a decrease in vascular trauma .
Sir patients aaderwent emergency toorlic vaive replace-
ment after salvaloplasty. The procedure was performed for
acute aortic regurgitation in four and left ventricular perfo-
ration in two
; three of these six patients died within the first
30 days after operation.
Discussion
indications for valvukplasly. Although aortic valve re-
placement is the treatment of choice for patients with
symptomatic aortic stenosis . there are subsets of patients in
whom it is problematic. Although age is not itself a conttain-
dieation to valve replacement . The risks of operation arc
increased in elderly patients (9-12) . In ocrogenariens, a
peooperative 30 day mortality rate of 20% to 30% has been
reported (11)
.
In patients >70 years of age, the perioperative
mortality rate ranges from 7% to 15%, depending on the
degree of coronary artery disease and the need for other
surgical procedures as well as on the baseline hemodynantie
status (9.10,122). Magovern et al. (9) found a 25% operative
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mortality rate in elderly patients with hcmodynamic insta-
bility . There are other subsets
of patients who . because they
have associated medical conditions (for example, chronic
obstractivc lung disease or malignancy), either are not
surgical candidates or are higher risk surgical candidates .
In these patient subsets, the use of percutaneous aortic
balloon valvutoplasty has received considerable interest as
an all ^_motive treatment. However, subsequent to this initial
enthusiasm, the risks and follow-up events in these patients
have been the subject of concern
{3-5,131
. In-hospital mor-
tality rates from 3 .5% to 7,5% have been reported, and the
follow-up incidence of restenosis is approximately 50%% at 6
to 12 months. In the current series, the mortality rate was
7
.5%. This series was composed orpa4ents who underwent
valvutoplasty from December I . 1986 to October 30, 1997,
and therefore the results represent an early experience with
a new technique.
Factors associated with postvalvuloplssty mortality
. In
this series, the factors associated with an increased inci-
dence of death included a lower left ventricular systolic
blood pressure and a lower cardiac output at baseline ; they
thereby mirror the status of left ventricular function, In
addition, patients who died during the in-hospital period had
more severe aortic stenosis at h Aseline study . More impor-
tant, a less successful procedure .iso was associated with
poorer outcome; both a more severe residual stenosis and a
smaller final aortic valve area were associated with increased
mortality, The most powerful Factor associated with a fatal
outcome was a procedural complication. Increased operator
experience as well as new technologic advances have the
potential for decreasing the frequency with which these
complications occur, although given the advanced age of the
patients, the associated diseases and the large size of the
equipment used, complications undoubtedly will remain .
Factors associated with complications
. Not all complica-
tions were associated with marked increases in mortality .
However, as would be expected, the more severe the
complication, the higher the mortality rate ; with myocardial
perforation or ventricular tachycardialfibrillalion . the rate
was 56% and 53%, respectively . The most important specific
factors associated with increased complications were
female
gender, the presence of coronary artery disease and more
severe functional class (New York Heart Association) at
baseline, Other factors included the use of a double balloon
technique and early experience in the study ; as the study
continued and as experience increased and equipment
changed, the chance of complications decreased, mainly in
rotation to a decrease in vascular injury
. Despite the statis-
tically significant associations between these factors and the
JACC Vol. 17. No. 1
Jsnaary 1991
:159-92
development of complications, the predictive value was low
and the model predicted complications accurately in only
59% of
the patients .
In most patients undergoing Boric valve dilation, there is
only moderate improvement in aortic valve hemedynamics
(3-6).
During the follow-up period there is a substantial
incidence of adverse cardiac events and a high incidence of
restenosis (from 50% io 75%) . Nevertheless, many patients,
even those with restenosis continue to have symptomatic
improvement . Because of this palliation in symptoms, the
technique does other beneftls for select subsets of patients
with severe aortic stencils . Identifying which patients are
associated with increased complications may improve pa-
tient selection and allow more accurate assessment of the
riskfienefit ratio for this specific patient subset .
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